NWA’s NOWDiagnostics Chosen as Endeavor Entrepreneur at 7th Virtual International Selection Panel

Bentonville, AR — Endeavor concluded the 7th Virtual International Selection Panel (ISP) with the selection of nine new high-impact entrepreneurs representing 1,310 companies from 37 markets around the world, including Northwest Arkansas’ Now Diagnostics entrepreneurs, Kevin Clark and Jeremy Wilson.

NOWDiagnostics is a developer and manufacturer of medical devices that deliver an innovative diagnostics testing solution for use at the point-of-care and at home. The company’s diagnostic tests simplify the process of detecting diseases and common ailments such as food intolerance, allergies, STIs and respiratory/chronic illnesses. Its innovative tests deliver results in less than 15 minutes, enabling patients and caregivers to make quicker, more intelligent healthcare choices. With eight tests CE Marked, one FDA 510k cleared for use in the U.S., and an additional 36 tests in the pipeline including COVID-19 antibody and antigen tests, NDx is dedicated to the commercialization of affordable, rapid diagnostic tests that deliver accurate, laboratory-quality results with just a drop of blood or saliva.

Interested in learning more? Read full article here.

NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases, with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics products have the potential to decrease the waiting period to determine test results by days. For more information about NOWDiagnostics, visit www.nowdx.com. For more information about the ADEXUSDx® COVID-19 Test, including its intended use, features, benefits and limitations, and directions for use, visit www.c19development.com. The ADEXUSDx® COVID-19 Test will be distributed by C19 Development, LLC, a wholly owned subsidiary of NOWDiagnostics. Laboratories may contact www.c19development.com/order to place an order.


NOWDiagnostics Company Contact
Beth Cobb, Director of Operations
Email: [email protected]

NOWDiagnostics Media Contact
Claire Burghoff, CGA Group
Email: [email protected] 

1 thought on “NWA’s NOWDiagnostics Chosen as Endeavor Entrepreneur at 7th Virtual International Selection Panel”

  1. At Long Last, an issue that I am overzealous about. I have looked for information of this topic for the last several hours. Your site is greatly prized.

Comments are closed.